A parallel group cohort to determine the measurement properties of an early inflammatory arthritis detection tool

Rheumatology (United Kingdom)

Volumn 52, Issue 11, 2013, Pages 2077-2085

  Tavares, Ruben ^a   Huang, Selena ^b   Bykerk, Vivian P ^c,d   Bell, Mary J ^b  

^a UNCOVER Clinical Research Company   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

^d MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Arthritis; Early diagnosis; Psychometrics; Rheumatoid; Triage; Validation studies

Indexed keywords

ADOLESCENT; ADULT; ALGORITHM; AREA UNDER THE CURVE; ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION COEFFICIENT; EMERGENCY HEALTH SERVICE; FEMALE; HUMAN; INFLAMMATORY ARTHRITIS DETECTION TOOL; INTERNAL CONSISTENCY; KUDER RICHARDSON COEFFICIENT; LIKERT SCALE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RHEUMATOID ARTHRITIS; TERTIARY HEALTH CARE; TEST RETEST RELIABILITY;

ARTHRITIS; EARLY DIAGNOSIS; PSYCHOMETRICS; RHEUMATOID; TRIAGE; VALIDATION STUDIES;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ARTHRITIS, RHEUMATOID; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TRIAGE; YOUNG ADULT;

EID: 84886241218     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket190     Document Type: Article

References (44)

1. Knevel R, Schoels M, Huizinga TWJ et al. Current evidence for a strategic approach to the management of rheumatoid arthritis with disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis. Ann Rheum Dis 2010;69:987-94.
2. Egsmose C, Lund B, Borg G et al. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. J Rheumatol 1995;22:2208-13.
3. The HERA Study Group. A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA study. Am J Med 1995;98:156-68.
4. van der Heide A, Jacobs JW, Bijlsma JW et al. The effectiveness of early treatment with 'second-line' antirheumatic drugs. A randomized, controlled trial. Ann Intern Med 1996;124:699-707.
5. Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, Allaart CF et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005;52:3381-90.
6. Finckh A, Liang MH, van Herckenrode CM et al. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis. Arthritis Rheum 2006;55:864-72.
7. Smolen JS, Landewe R, Breedveld FC et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69:964-75.
8. Nell VPK, Machold KP, Eberl G et al. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology 2004;43:906-14.
9. Green M, Marzo-Ortega H, McGonagle D et al. Persistence of mild, early inflammatory arthritis: the importance of disease duration, rheumatoid factor, and the shared epitope. Arthritis Rheum 1999;42:2184-8.
10. Tavares R, Pope JE, Tremblay JL et al. Time to disease modifying anti-rheumatic drug treatment in rheumatoid arthritis and its predictors: a national, multi-center, retrospective cohort. J Rheumatol 2012;39:2088-97.
11. Hernandez-Garcia C, Vargas E, Abasolo L et al. Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis. J Rheumatol 2000;27:2323-8.
12. Kiely P, Williams R, Walsh D et al. Contemporary patterns of care and disease activity outcome in early rheumatoid arthritis: the ERAN cohort. Rheumatology 2009;48:57-60.
13. Robinson PC, Taylor WJ. Time to treatment in rheumatoid arthritis: factors associated with time to treatment initiation and urgent triage assessment of general practitioner referrals. J Clin Rheumatol 2010;16:267-73.
14. Wiles N, Symmons DP, Harrison B et al. Estimating the incidence of rheumatoid arthritis: trying to hit a moving target? Arthritis Rheum 1999;42:1339-46.
15. Emery P, Breedveld FC, Dougados M et al. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis 2002;61:290-7.
16. Combe B, Landewe R, Lukas C et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66:34-45.
17. Tavares R, Wells GA, Scarf J et al. Classification of rheumatologic opinion on early inflammatory arthritis: harmonization of a heterogeneous standard. Arthritis Care Res 2010;62:1407-14.
18. Aletaha D, Neogi T, Silman AJ et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-81.
19. Marhadour T, Jousse-Joulin S, Chales G et al. Reproducibility of joint swelling assessments in long-lasting rheumatoid arthritis: influence on disease activity score-28 values (SEA-Repro Study Part I). J Rheumatol 2010;37:932-7.
20. Bell MJ, Tavares R, Guillemin F et al. Development of a self-administered early inflammatory arthritis detection tool. BMC Musculoskelet Disord 2010;11:50.
21. Tavares R, Wells GA, Bykerk VP et al. Validation of a selfadministered inflammatory arthritis detection tool for rheumatology triage. J Rheumatol 2013;40:417-24.
22. Barbour JA, Binding J, Bridges M et al. Evaluation of a screening tool for inflammatory joint disease. Ann Rheum Dis 2003;62:187-8.
23. De Coster C, Fitzgerald A, Cepoiu M et al. Priority-setting tools for rheumatology disease referrals: a review of the literature. Clin Rheumatol 2008;27:1411-6.
24. Graydon SL, Thompson AE. Triage of referrals to an outpatient rheumatology clinic: analysis of referral information and triage. J Rheumatol 2008;35:1378-83.
25. Fitzgerald A, De Coster C, McMillan S et al. Relative urgency for referral from primary care to rheumatologists: the priority referral score. Arthritis Care Res 2011;63:231-9.
26. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
27. Dougados M, van der Linden S, Juhlin R et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
28. Katz PP, Radvanski DC, Allen D et al. Development and validation of a short form of the valued life activities disability questionnaire for rheumatoid arthritis. Arthritis Care Res 2011;63:1664-71.
29. Bremander A, Wikström I, Larsson I et al. Cultural adaptation, validity, reliability and responsiveness of the Swedish version of the effective musculoskeletal consumer scale (EC-17). Musculoskeletal Care 2012;10: 43-50.
30. Paulsen T, Grotle M, Garratt A et al. Development and psychometric testing of the patient-reported measure of activity performance of the hand (MAP-Hand) in rheumatoid arthritis. J Rehabil Med 2010;42:636-44.
31. Kelsey JL. Methods in observational epidemiology, 2nd edn. New York: Oxford University Press, 1996.
32. Kuder GF, Richardson MW. The theory of the estimation of test reliability. Psychometrika 1937;2:151-60.
33. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.
34. Wittes J, Wallenstein S. The power of the Mantel-Haenzal test. J Am Stat Assoc 1987;82:1104-9.
35. Kruskal W, Wallis AW. Use of ranks in one-criterion variance analysis. J Am Stat Assoc 1952;47:583-621.
36. Wilcoxon F. Individual comparisons by ranking methods. Biometrics 1945;1:80-3.
37. Shrout PE, Fleiss JL. Interclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-8.
38. Norman GR, Streiner DL. Biostatistics: the bare essentials, 2nd edn. Hamilton, ON, Canada: B.C. Decker, 2000.
39. Walter SD, Eliasziw M, Donner A. Sample size and optimal designs for reliability studies. Stat Med 1998;17: 101-10.
40. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33: 159-74.
41. Nunnally J, Bernstein I. Psychometric theory. New York: McGraw-Hill, 1994.
42. Alves C, Luime JJ, van Zeben D et al. Diagnostic performance of the ACR/EULAR 2010 criteria for rheumatoid arthritis and two diagnostic algorithms in an early arthritis clinic (REACH). Ann Rheum Dis 2011;70: 1645-7.
43. Bleeker SE, Moll HA, Steyerberg EW et al. External validation is necessary in prediction research: a clinical example. J Clin Epidemiol 2003;56:826-32.
44. Tavares R, Pope JE, Tremblay J-L et al. Early management of newly diagnosed rheumatoid arthritis by Canadian rheumatologists: a national, multicenter, retrospective cohort. J Rheumatol 2011;38:2342-5.